Global Partnerships and Collaborations Validate Our Platform
We are establishing a global network of partnerships and collaborations – from discovery to development. These alliances leverage our AI-powered antibody technology platform to help bring innovative therapeutics to patients. Meanwhile, key clinical collaborations enable advancement of our internal wholly-owned pipeline candidates.
SAFEbody Development
DPL Discovery
Clinical Collaborations
Validation by Chinese Entities
